Patents by Inventor Tina Christine Lavranos

Tina Christine Lavranos has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antibody and checkpoint inhibitor combination therapy
    Patent number: 11655304
    Abstract: The present invention provides a combination therapy for treatment of a tumour in a subject. The combination therapy comprises administration of (i) an antibody directed against cancer stem cells and (ii) a checkpoint inhibitor.
    Type: Grant
    Filed: September 14, 2017
    Date of Patent: May 23, 2023
    Assignee: Bionomics Limited
    Inventors: Tina Christine Lavranos, Daniel John Inglis, Christopher L. Reyes
  • ANTIBODY AND CHECKPOINT INHIBITOR COMBINATION THERAPY
    Publication number: 20190263925
    Abstract: The present invention provides a combination therapy for treatment of a tumour in a subject. The combination therapy comprises administration of (i) an antibody directed against cancer stem cells and (ii) a checkpoint inhibitor.
    Type: Application
    Filed: September 14, 2017
    Publication date: August 29, 2019
    Inventors: Tina Christine LAVRANOS, Daniel John INGLIS, Christopher L. REYES
  • Compositions and methods for angiogenesis-related molecules and treatments
    Patent number: 7667028
    Abstract: Short interfering RNA (siRNA) molecules which modulate the expression of an angiogenesis-related gene by RNA interference are described. Short hairpin RNA (shRNA) molecules comprising said siRNA molecules are also described. These molecules can target all, or specific, isoforms of the gene. The use of these molecules and of isoforms of the gene for the treatment and diagnosis of angiogenesis-related disorders is also described.
    Type: Grant
    Filed: August 9, 2005
    Date of Patent: February 23, 2010
    Assignee: Bionomics Limited
    Inventors: Gabriel Kremmidiotis, Tina Christine Lavranos, Annabell Frances Leske
  • Compositions and Methods for Angiogenesis-Related Molecules and Treatments
    Publication number: 20080119430
    Abstract: Short interfering RNA (siRNA) molecules which modulate the expression of an angiogenesis-related gene by RNA interference are described. Short hairpin RNA (shRNA) molecules comprising said siRNA molecules are also described. These molecules can target all, or specific, isoforms of the gene. The use of these molecules and of isoforms of the gene for the treatment and diagnosis of angiogenesis-related disorders is also described.
    Type: Application
    Filed: August 9, 2005
    Publication date: May 22, 2008
    Applicant: BIONOMICS LIMITED
    Inventors: Gabriel Kremmidiotis, Tina Christine Lavranos, Annabell Frances Leske